OUTLIERS IN GLIOBLASTOMA OUTCOME. DEEP GENOMIC ANALYSIS OF SHORT-TERM AND LONG-TERM SURVIVORS OF GBM TO UNDERSTAND THE MOLECULAR BASIS OF RESPONSE TO THERAPY AND TO GUIDE NEW TREATMENT DEVELOPMENT.